Markers of renal damage in patients with risk factors of chronic renal disease

Authors

  • Yoandis Castellanos Castillo Policlínico Docente “30 de Noviembre”, Santiago de Cuba
  • Juana Adela Fong Estrada Hospital Universitario “Ambrosio Grillo Portuondo”, Santiago de Cuba
  • José Manuel Vázquez Trigo Facultad de Ciencias Médicas No. 1, Santiago de Cuba
  • Jacquelin Oliva Fong Policlínico “Luis Ramírez López”, Cobre, Santiago de Cuba

Keywords:

chronic renal disease, renal marker, risk factor, primary health care.

Abstract

A descriptive and cross-sectional study of 46 patients older than 18 years, belonging to the doctor’s office 34 of the health area in Majagua, Ciego de Ávila, was carried out from September, 2015 to February, 2016. The complementary tests were indicated to all the members of the series, such as microalbuminuria, glomerular filtration rate, creatinine, Addis and urea counts. The imagenologic studies were not carried out due to the long distance, difficulties with the transportation and the ultrasonography equipment. The disorder of renal markers was present in half of those affected patients with risk factors, which allowed to detect earlier the chronic renal disease in that population group.  

Downloads

Download data is not yet available.

References

1. Costa GMA, Pinheiro MBGN, Medeiros SM de, Costa RR de O, Cossi MS. Calidad de vida en pacientes con insuficiencia renal crónica en hemodiálisis. Enferm glob. 2016 [citado 4 Mar 2017]; 15 (43). Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1695-61412016000300003

2. Martínez Pérez D, Pérez de Alejo Rodríguez L, Moré Chang CX, Rodríguez Viera R, Dupuy Núñez JC. Estudios de laboratorio clínico para la detección de la enfermedad renal crónica en grupos poblacionales de riesgo. MEDISAN. 2016 [citado 4 Mar 2017]; 20 (1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192016000100008&lng=es

3. KDIGO. Definition and classification of CKD. Kidney International Supplements. 2013; 3:19-62.

4. United Stated Renal Data System. Atlas of CKD and ESRD. Bethesda (MD): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2013 [citado 9 Mar 2017]. Disponible en: https://www.usrds.org/atlas13.aspx

5. Gentille Lorente DI, Salvadó Usach T. Insuficiencia renal en pacientes cardiológicos: buscar para encontrar. Rev Méd Chile. 2015 [citado 9 Mar 2017]; 143 (9): 1105-1113. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015000900002&lng=es.http://dx.doi.org/10.4067/S0034-8872015000900002

6. Tamayo Orozco JA. La cobertura nacional de la enfermedad renal crónica. Gac Méd Méx. 2008 [citado 20 Mar 2017]; 144 (6). Disponible en: http://www.medigraphic.com/pdfs/gaceta/gm-2008/gm086k.pdf

7. Lopes MB, Araújo LQ, Passos MT, Nishida SK, Kirsztajn GM, Cendoroglo MS, et al. Estimation of glomerular filtration rate from serum creatine and cystatin C in octogenarians and nonagenarians. BMC Nephrology. 2013; 14:265-74.

8. Cecil. Enfermedad renal crónica. En: Tratado de Medicina Interna. 23 ed. Barcelona: Elsevier Saunders; 2009. p. 969.

9. López Labrada R, Casado Méndez PR, Zamora R, Del Castillo Remón IL. Eficacia de las fórmulas MDRD-abreviada y Cockcroft- Gault para la detección de insuficiencia renal crónica en la atención primaria. MEDISAN. 2014 [citado 8 Feb 2017]; 18 (2). Disponible en: http://bvs.sld.cu/revistas/san/vol18_2_14/san07214.htm

10. Nagai K, Saito C, Watanabe F, Ohkubo R, Sato C, Kawamura T, et al. Annual incidence of persistent proteinuria in the general population from Ibaraki annual urinalysis study. Clin Exp Nephrol. 2013; 17 (2):255-60.

11. Sandilands E, Dhaun N, Dear J, Webb D. Measurement of renal function in patients with chronic kidney disease. Br J Clin Pharmacol. 2013; 76 (4):504-15.



12. Stevens PE, Levin A. Enfermedad renal crónica (guía de práctica clínica). Guía para la evaluación, manejo y tratamiento de la enfermedad renal crónica que no se encuentre bajo terapia de reemplazo renal. Ann Intern Med. 2013 [citado 17 Feb 2017]; 158. Disponible en: http://www.intramed.net/contenidover.asp?contenidoID=80665

13. Acuña L, Sánchez P, Soler LA, Alvis LF. Enfermedad renal en Colombia: prioridad para la gestión de riesgo. Rev Panam Salud Publica. 2016 [citado 17 Feb 2017]; 40 (1). Disponible en: https://scielosp.org/article/rpsp/2016.v40n1/16-22/es/

14. Tanaka S, Takase H, Dohi Y, Kimura G. The prevalence and characteristics of microalbuminuria in the general population: a cross-sectional study. BMC Res Notes. 2013; 6 (1):256-61.

15. Miranda Folch JJ, Vega Jiménez J, García Cuervo D, Alemán Marichal B. Los puntos de contacto entre enfermedad renal crónica y enfermedad cerebrovascular. Rev Med Electrón. 2016 [citado 6 Mar 2017]; 38(5). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18242016000500010

16. Tani Y, Nakayama M, Terawaki H, Iseki K, Watanabe T. Comparison of albuminuria test and urine test strip in Japanese hypertensive patients: AVA-E study. Clin Nephrol. 2015; 84 (5): 270-3.

17. Martínez Castelao A, Górriz JL, Bover J, Segura de la Morena J, Cebollada J, Escalada J, et al. Documento de consenso para la detección y manejo de la enfermedad renal crónica. Atención Primaria. 2014 [citado 9 Mar 2017]; 46 (9). Disponible en: http://www.sciencedirect.com/science/article/pii/S021265671400273X

18. Cerqueira DP, Tavares JR, Machado RC. Factores de predicción de la insuficiencia renal y el algoritmo de control y tratamiento. Rev Latino-Am Enfermagem. 2014 [citado 6 Mar 2017]; 22 (2). Disponible en: http://www.scielo.br/scielo.php?pid=S0104-11692014000200211&script=sci_arttext&tlng=es

Downloads

Published

2018-02-13

How to Cite

1.
Castellanos Castillo Y, Fong Estrada JA, Vázquez Trigo JM, Oliva Fong J. Markers of renal damage in patients with risk factors of chronic renal disease. MEDISAN [Internet]. 2018 Feb. 13 [cited 2025 Sep. 20];22(2). Available from: https://medisan.sld.cu/index.php/san/article/view/1945

Issue

Vol. 22 No. 2 (2018): MEDISAN

Section

Original Articles

License

All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.